Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (BMEA)
CUSIP: 09077A106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 79,264,970
- Total 13F shares
- 28,737,423
- Share change
- +7,583,257
- Total reported value
- $51,727,041
- Put/Call ratio
- 34%
- Price per share
- $1.80
- Number of holders
- 85
- Value change
- +$13,133,320
- Number of buys
- 49
- Number of sells
- 60
Quarterly Holders Quick Answers
What is CUSIP 09077A106?
CUSIP 09077A106 identifies BMEA - Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09077A106:
Top shareholders of BMEA - Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sotirios Stergiopoulos |
3/4/5
|
Director |
—
class O/S missing
|
4,400,000
|
$16,643,000 | — | 17 Sep 2021 | |
| A2A Pharmaceuticals, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,500,000
|
$13,238,750 | — | 31 May 2023 | |
| FMR LLC |
13F
|
Company |
6.9%
|
5,435,803
|
$11,578,261 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
4.5%
|
3,570,872
|
$7,605,957 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.3%
from 13D/G
|
2,159,991
|
$4,600,781 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13D/G
|
— |
4%
|
1,451,990
|
$3,194,378 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
1,378,064
|
$2,935,276 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.34%
|
270,087
|
$2,133,901 | — | 31 Mar 2025 | |
| Aisling Capital Management LP |
13F
|
Company |
1%
|
798,757
|
$1,701,352 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
625,953
|
$1,333,549 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.75%
|
597,374
|
$1,272,407 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.75%
|
594,121
|
$1,265,478 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.63%
|
500,000
|
$1,065,000 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.62%
|
491,000
|
$1,045,830 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
480,080
|
$1,022,571 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.6%
|
472,359
|
$1,006,125 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
297,585
|
$633,856 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.36%
|
281,739
|
$600,104 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
278,119
|
$592,393 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
264,028
|
$562,380 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.3%
|
240,844
|
$512,998 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.3%
|
236,876
|
$504,546 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
181,380
|
$386,339 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.22%
|
177,842
|
$378,804 | — | 31 Mar 2025 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.21%
|
165,937
|
$353,446 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.18%
|
145,901
|
$311,000 | — | 31 Mar 2025 | |
| Franco Valle |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
188,240
mixed-class rows
|
$264,591 | — | 30 Nov 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.15%
|
116,687
|
$248,543 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
102,493
|
$218,310 | — | 31 Mar 2025 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.11%
|
90,384
|
$192,520 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.11%
|
87,089
|
$185,500 | — | 31 Mar 2025 | |
| Marex Group plc |
13F
|
Company |
0.11%
|
85,000
|
$181,050 | — | 31 Mar 2025 | |
| Sculptor Capital LP |
13F
|
Company |
0.11%
|
84,800
|
$180,624 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.1%
|
76,285
|
$162,487 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
73,586
|
$156,739 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
69,340
|
$147,694 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.08%
|
63,300
|
$134,829 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
59,308
|
$126,501 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.07%
|
57,361
|
$122,179 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
51,445
|
$109,578 | — | 31 Mar 2025 | |
| GRIFFIN ASSET MANAGEMENT, INC. |
13F
|
Company |
0.06%
|
51,300
|
$109,269 | — | 31 Mar 2025 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.06%
|
50,550
|
$107,672 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.06%
|
45,238
|
$96,357 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
40,477
|
$86,206 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.05%
|
38,253
|
$81,479 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
35,300
|
$75,189 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
33,688
|
$71,754 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
31,716
|
$67,555 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
28,466
|
$60,633 | — | 31 Mar 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.03%
|
24,101
|
$51,335 | — | 31 Mar 2025 |
Institutional Holders of Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (BMEA) as of Q2 2025
As of 30 Jun 2025,
Biomea Fusion, Inc. - Common Stock, $0.0001 par value per share (BMEA) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,737,423 shares.
The largest 10 holders included
FMR LLC, HEIGHTS CAPITAL MANAGEMENT, INC, Cormorant Asset Management, LP, Aisling Capital Management LP, VANGUARD GROUP INC, Woodline Partners LP, Blue Owl Capital Holdings LP, BlackRock, Inc., FEDERATED HERMES, INC., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
93
Q2 2025 holders
85
Holder diff
-8
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.